Symplocamide A as marine-derived proteasome inhibitor: a promising scaffold for targeted cancer therapy.
Saved in:
| Title: | Symplocamide A as marine-derived proteasome inhibitor: a promising scaffold for targeted cancer therapy. |
|---|---|
| Authors: | Dincturk HC; Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Türkiye., Bilgin AB; Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Türkiye., Köroğlu DG; Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Türkiye., Gozukirmizi CK; Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Türkiye., Ozkan G; Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Türkiye., Capanoglu E; Department of Food Engineering, Faculty of Chemical and Metallurgical Engineering, Istanbul Technical University, Maslak, Istanbul, Türkiye. capanogl@itu.edu.tr., Setzer WN; Aromatic Plant Research Center, 230 N 1200 E, Suite 100, Lehi, UT, 84043, USA.; Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL, 35899, USA., Büsselberg D; Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, P.O. Box 24144, Doha, Qatar., Calina D; Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania. calinadaniela@gmail.com., Sharifi-Rad J; Universidad Espíritu Santo, Samborondón, 092301, Ecuador. javad.sharifirad@gmail.com.; Centro de Estudios Tecnológicos y Universitarios del Golfo, Veracruz, Mexico. javad.sharifirad@gmail.com.; Department of Medicine, College of Medicine, Korea University, Seoul, 02841, Republic of Korea. javad.sharifirad@gmail.com. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2025 Jul 19; Vol. 42 (8), pp. 351. Date of Electronic Publication: 2025 Jul 19. |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
